Evidence map›Paper›PMID 38070030›Full record

ArticleJournal of neurology2024

Evidence for converging pathophysiology in complex regional pain-syndrome and primary headache disorders: results from a case-control study.

Matthias Wiemann, Nikolas Zimowski, Sarah-Luis Blendow, Elena Enax-Krumova, Steffen Naegel, Robert Fleischmann, Sebastian Strauss

Open access · hybridAbstract read
In one paragraph

Article in Journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Matthias Wiemann *Department of Neurology, University Medicine Greifswald, Greifswald, Germany.
Nikolas Zimowski *Department of Trauma, Reconstructive Surgery and Rehabilitative Medicine, University Medicine Greifswald, Greifswald, Germany.
Sarah-Luis BlendowDepartment of Neurology, University Medicine Greifswald, Greifswald, Germany.
Elena Enax-KrumovaDepartment of Neurology, BG University Hospital Bergmannsheil gGmbH, Ruhr University Bochum, Bochum, Germany.
Steffen NaegelDepartment of Neurology, Martin Luther University Halle-Wittenberg and University Hospital Halle, Halle (Saale), Germany.
Robert FleischmannDepartment of Neurology, University Medicine Greifswald, Greifswald, Germany.
Sebastian StraussDepartment of Neurology, University Medicine Greifswald, Greifswald, Germany. sebastian.strauss@med.uni-greifswald.de.ORCID http://orcid.org/0000-0001-5865-4427
Universitätsmedizin Greifswald · DEAlfried Krupp Hospital · DEBG University Hospital Bergmannsheil Bochum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeuroinflammation and maladaptive neuroplasticity play pivotal roles in migraine (MIG), trigeminal autonomic cephalalgias (TAC), and complex regional pain syndrome (CRPS). Notably, CRPS shares connections with calcitonin gene-related peptide (CGRP) in its pathophysiology. This study aims to assess if the documented links between CRPS and MIG/TAC in literature align with clinical phenotypes and disease progressions. This assessment may bolster the hypothesis of shared pathophysiological mechanisms.

methodsPatients with CRPS (n = 184) and an age-/gender-matched control group with trauma but without CRPS (n = 148) participated in this case-control study. Participant answered well-established questionnaires for the definition of CRPS symptoms, any headache complaints, headache entity, and clinical management.

resultsPatients with CRPS were significantly more likely to suffer from migraine (OR: 3.23, 95% CI 1.82-5.85), TAC (OR: 8.07, 95% CI 1.33-154.79), or non-classified headaches (OR: 3.68, 95% CI 1.88-7.49) compared to the control group. Patients with MIG/TAC developed CRPS earlier in life (37.2 ± 11.1 vs 46.8 ± 13.5 years), had more often a central CRPS phenotype (60.6% vs. 37.0% overall) and were three times more likely to report allodynia compared to CRPS patients with other types of headaches. Additionally, these patients experienced higher pain levels and more severe CRPS, which intensified with an increasing number of headache days. Patients receiving monoclonal antibody treatment targeting the CGRP pathway for headaches reported positive effects on CRPS symptoms.

conclusionThis study identified clinically relevant associations of MIG/TAC and CRPS not explained by chance. Further longitudinal investigations exploring potentially mutual pathomechanisms may improve the clinical management of both CRPS and primary headache disorders.

trial registrationGerman Clinical Trials Register (DRKS00022961).

Indexed as

Complex Regional Pain SyndromesMigraine DisordersCalcitonin Gene-Related PeptideCase-Control StudiesHeadacheHumansCalcitonin Gene-Related PeptideCentral sensitizationCGRPComplex regional pain syndromeCRPSMigraine

Identifiers

PMID38070030
PMCPMC10972976
OpenAlexW4389506340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.